A 52-week, randomized, double-blind, double dummy, placebo- and active- controlled XXX, parallel-group, study to evaluate the efficacy and safety of two doses of  XXX add-on to maintenance triple therapy in subjects with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis